Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients - Concepedia

Concepedia

Publication | Closed Access

Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients

48

Citations

16

References

2011

Year

Edward Gane, Catherine Stedman, Alicja Wiercińska‐Drapało, Andrzej Horban, Linda Chang, Ying Zhang, Pratibha Sampeur, Isabel Nájera, Patrick F. Smith, Nancy S. Shulman,

Journal of Hepatology

HepatologyHepatitis CViral HepatitisHepatitis C PatientsAntiviral ActivityImmunologyMedicineHepatitisVirologyAntiviral Drug DevelopmentAntiviral TherapyPharmacotherapyAntiviral DrugPeg-ifn α-2A/rbvPharmacologyAntiviral Compound

References

	Year	Citations

Page 1

Page 1